Incyte (INCY) Free Cash Flow (2010 - 2026)
Incyte (INCY) posted Free Cash Flow of $367.7 million for Q1 2026, down 36.09% on a QoQ basis from $575.4 million in Q4 2025, and up 39.72% year-over-year from $263.2 million in Q1 2025.
Incyte (INCY) Free Cash Flow (2010 - 2026) Analysis & Trends
Incyte's Free Cash Flow history runs 17 years deep, the most recent figure standing at $367.7 million for Q1 2026.
- Quarterly Free Cash Flow rose 39.72% year-over-year to $367.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 414.97% YoY) and the FY2025 annual result came in at $1.4 billion, up 465.52% from the prior year.
- Free Cash Flow was $367.7 million for Q1 2026 at Incyte, down from $575.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $575.4 million in Q4 2025 and bottomed at -$576.0 million in Q2 2024.
- A 5-year average of $204.9 million and a median of $263.2 million in 2025 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 301.02% in 2024, while the deepest fall reached 288.74% in 2024.
- Incyte's Free Cash Flow stood at $289.0 million in 2022, then plunged by 40.18% to $172.9 million in 2023, then soared by 72.64% to $298.5 million in 2024, then surged by 92.76% to $575.4 million in 2025, then sank by 36.09% to $367.7 million in 2026.
- Business Quant data shows INCY's Free Cash Flow at $367.7 million in Q1 2026, $575.4 million in Q4 2025, and $526.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 367.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 367.72 Mn |
| Mar 31, 2026 | 367.72 Mn |
| Dec 31, 2025 | 575.36 Mn |
| Dec 31, 2025 | 575.36 Mn |
| Sep 30, 2025 | 526.45 Mn |
| Sep 30, 2025 | 526.45 Mn |
| Jun 30, 2025 | 43.59 Mn |
| Jun 30, 2025 | 43.59 Mn |
| Mar 31, 2025 | 263.18 Mn |
| Mar 31, 2025 | 263.18 Mn |
| Dec 31, 2024 | 298.49 Mn |
| Dec 31, 2024 | 298.49 Mn |
| Sep 30, 2024 | 308.13 Mn |
| Sep 30, 2024 | 308.13 Mn |
| Jun 30, 2024 | -575.98 Mn |
| Jun 30, 2024 | -575.98 Mn |
| Mar 31, 2024 | 218.43 Mn |
| Mar 31, 2024 | 218.43 Mn |
| Dec 31, 2023 | 172.90 Mn |
| Dec 31, 2023 | 172.90 Mn |